Optimizing Gestational Weight Gain for Prevention of Gestational Diabetes Mellitus in Malaysia

NCT ID: NCT05489536

Last Updated: 2022-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Gestational weight gain (GWG) has been closely related to health outcomes, particularly in gestational diabetes mellitus (GDM). Pregnant women may be particularly motivated to make healthy lifestyle changes. Previous studies showed that lifestyle modification interventions (diet and exercise) may be successful in reducing GWG in high-risk women but their effects on the incidence of GDM and other adverse perinatal outcomes have been limited. The research question for the future full randomized trial is whether an optimizing healthy GWG programme focusing on lifestyle (diet and physical activity) feasible to decrease the risk of GDM in a developing country. Thus, this study aims to evaluate the effectiveness of a web/smartphone-based lifestyle program in optimizing gestational weight gain (GWG) to prevent the incidence of GDM.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General objective: To determine the effectiveness of a web/smartphone-based lifestyle program on optimizing gestational weight gain (GWG) to prevent the incidence of GDM.

Specific objectives:

1. To compare changes in the primary outcome (incidence of GDM) between pregnant mothers receiving web/smartphone-based lifestyle program (i.e. intervention group) and pregnant mothers not receiving web/smartphone-based lifestyle program (i.e. control group).
2. To compare changes in the secondary outcomes (GWG, dietary intake and physical activity) between pregnant mothers receiving web/smartphone-based lifestyle program (i.e. intervention group) and pregnant mothers not receiving web/smartphone-based lifestyle program (i.e. control group).

Study location: A total of nine (9) states are randomly selected to represent the Northern, Southern, East Coast and central regions of Peninsular Malaysia. The states are then randomly assigned to either the intervention states or control states. All maternal and child health (MCH) clinics in the top five highest populated districts are purposively selected.

Study design: This is a cluster-randomized, controlled trial (RCT), whereby states as clusters and will be randomly allocated into either intervention or control group. All pregnant women in each cluster will be included in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnant Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A Web/smartphone-based Lifestyle Program Intervention Group

As this study is designed specifically to isolate the effect of introducing the web/app into the existing care pathway, the intervention group will receive standard prenatal care provided by health clinics and the web/smartphone app.

Group Type EXPERIMENTAL

A web/smartphone-based lifestyle program package

Intervention Type BEHAVIORAL

There are two platforms for the lifestyle program, namely Health and Nutrition Education (HNE) website and HNE app. The participants are requested to download and register on the HNE website and the HNE app. The HNE app is Android and IOS compatible. Both the HNE website and app are designed to support self-directed learning and independently monitor their GWG and dietary intake during pregnancy. Both the HNE website and app will be passcode protected throughout the study period such that access is restricted to only participants in the intervention group.

The web/smartphone-based lifestyle program package consists of:

I. Health and Nutrition Education (HNE) resources II. Gestational Weight Gain (GWG) monitoring III. Dietary intake monitoring

Control Group

A standard usual prenatal care includes ten clinic visits for routine pregnancy checks (weight gain, iron status, blood pressure, fasting blood glucose etc.)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A web/smartphone-based lifestyle program package

There are two platforms for the lifestyle program, namely Health and Nutrition Education (HNE) website and HNE app. The participants are requested to download and register on the HNE website and the HNE app. The HNE app is Android and IOS compatible. Both the HNE website and app are designed to support self-directed learning and independently monitor their GWG and dietary intake during pregnancy. Both the HNE website and app will be passcode protected throughout the study period such that access is restricted to only participants in the intervention group.

The web/smartphone-based lifestyle program package consists of:

I. Health and Nutrition Education (HNE) resources II. Gestational Weight Gain (GWG) monitoring III. Dietary intake monitoring

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Malaysian women
* At any trimester of pregnancy
* All ethnicities (Malays, Chinese or Indians)
* With or without diseases (diabetes mellitus with/ without insulin, hypertension, dyslipidaemia, overweight/ obese)

Exclusion Criteria

* Medical diagnosis with major psychiatric problems (bipolar depression, schizophrenia, suicidal risk)
* Severe comorbidities (eg cardiac diseases, kidney diseases severe anemia) that require specific interventions
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The World Diabetes Foundation

OTHER

Sponsor Role collaborator

Universiti Putra Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chan Yoke Mun

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zalilah Mohd Shariff, PhD

Role: PRINCIPAL_INVESTIGATOR

Universiti Putra Malaysia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Health Clinics in Southern of Peninsular Malaysia

Johor Bahru, Johor, Malaysia

Site Status

Health Clinics in Northern of Peninsular Malaysia

Alor Star, Kedah, Malaysia

Site Status

Health Clinics in East Coast of Peninsular Malaysia

Kota Bharu, Kelantan, Malaysia

Site Status

Health Clinics in Southern of Peninsular Malaysia

Malacca, Malacca, Malaysia

Site Status

Health Clinics in Southern of Peninsular Malaysia

Seremban, Negeri Sembilan, Malaysia

Site Status

Health Clinics in Central of Peninsular Malaysia

Ipoh, Perak, Malaysia

Site Status

Health Clinics in Northern of Peninsular Malaysia

George Town, Pulau Pinang, Malaysia

Site Status

Health Clinics in Central of Peninsular Malaysia

Petaling Jaya, Selangor, Malaysia

Site Status

Health Clinics in East Coast of Peninsular Malaysia

Kuala Terengganu, Terengganu, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zalilah Mohd Shariff, PhD

Role: CONTACT

+603-97692472

Yoke Mun Chan, PhD

Role: CONTACT

+60397692433

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Zalilah Mohd Shariff, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UPM19062022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prevention of Gestational Diabetes
NCT01130012 COMPLETED NA
Active Patient GDM
NCT03802877 COMPLETED NA